We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

99 hedge funds and large institutions have $749M invested in Lexicon Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 103 → 99 (-4)

8% less capital invested

Capital invested by funds: $813M → $749M (-$63.6M)

26% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 35

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
99
Holders Change
-4
Holders Change %
-3.88%
% of All Funds
2.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
26
Reduced
35
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$3.89M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M
3
UBS AM
UBS AM
Illinois
+$750K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$265K
5
Morgan Stanley
Morgan Stanley
New York
+$219K

Top Sellers

1
State Street
State Street
Massachusetts
-$6.17M
2
RA
Royce & Associates
New York
-$2.07M
3
BFA
BlackRock Fund Advisors
California
-$1.47M
4
CNB
City National Bank
California
-$841K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$507K
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
26
ProShare Advisors
Maryland
$682K -$306K -28,485 -32%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$672K +$8.89K +828 +1%
Stifel Financial
28
Stifel Financial
Missouri
$628K -$74.1K -6,900 -11%
Invesco
29
Invesco
Georgia
$618K +$17.8K +1,656 +3%
TA
30
Teachers Advisors
New York
$515K -$14K -1,302 -3%
DekaBank Deutsche Girozentrale
31
DekaBank Deutsche Girozentrale
Germany
$476K -$26.1K -2,429 -5%
RPAM
32
Rhenman & Partners Asset Management
Sweden
$475K – – –
Swiss National Bank
33
Swiss National Bank
Switzerland
$475K +$31.9K +2,972 +8%
Morgan Stanley
34
Morgan Stanley
New York
$473K +$219K +20,408 +94%
Bank of America
35
Bank of America
North Carolina
$447K -$6.32K -588 -1%
Deutsche Bank
36
Deutsche Bank
Germany
$423K -$82.7K -7,698 -17%
UOTTAIMCU
37
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$403K – – –
TA
38
Teton Advisors
New York
$378K – – –
CS
39
Credit Suisse
Switzerland
$350K -$53.5K -4,977 -14%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$338K -$2.12K -197 -0.7%
WHI
41
William Harris Investors
Illinois
$329K – – –
NFA
42
Nationwide Fund Advisors
Ohio
$283K +$1.08K +101 +0.4%
State Board of Administration of Florida Retirement System
43
State Board of Administration of Florida Retirement System
Florida
$260K – – –
GI
44
GAMCO Investors
Connecticut
$258K +$26.1K +2,429 +12%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$254K -$40.2K -3,747 -14%
RTS
46
Round Table Services
New Jersey
$244K – – –
AIG
47
American International Group
New York
$244K -$7.8K -726 -3%
BA
48
BlackRock Advisors
Delaware
$232K -$32.5K -3,028 -13%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$224K – – –
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$199K +$28.9K +2,686 +18%
1
2
3 4 5

LXRX Hedge Fund Activity: Q2 2014 in Review

99 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q2 2014, worth a combined $749M — down 7.8% from $813M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of LXRX and 8 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 26 added.

The largest buyer was Norges Bank, adding an estimated $3.89M. The largest seller was State Street, cutting an estimated $6.17M.

  • 99 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q2 2014, down from 103 in Q1 2014.
  • Funds reported $749M of Lexicon Pharmaceuticals stock for Q2 2014, down 7.8% quarter-over-quarter.
  • 8 funds opened new Lexicon Pharmaceuticals positions in Q2 2014 and 12 closed out, a net change of -4 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q2 2014 was Norges Bank, an estimated $3.89M added.
  • The largest Lexicon Pharmaceuticals seller in Q2 2014 was State Street, an estimated $6.17M sold.

Based on aggregated 13F filings for Q2 2014.